TMS Therapy: How Transcranial Magnetic Stimulation Works and Who It Helps

TMS therapy (transcranial magnetic stimulation, often called rTMS) works by sending focused magnetic pulses through the scalp into the left dorsolateral prefrontal cortex, where they induce small electrical currents that make underactive mood circuits fire. It mainly helps adults with major depression that has not improved on antidepressants: in a study of 307 patients at 42 US practices, Carpenter and colleagues (2012) reported a 58% response rate and a 37% remission rate.

The FDA has cleared TMS devices for major depressive disorder (2008), obsessive-compulsive disorder (2018), smoking cessation (2020) and depression with anxiety symptoms (2021). Treatment is supervised by a psychiatrist or other physician, runs five days a week for about four to six weeks on the standard schedule, and needs no anesthesia. The TMS treatment guide covers protocols in more depth, and the national directory of TMS clinics lists providers by state and city.

---

What Is TMS Therapy, Really?

Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation treatment for depression and several other conditions. It is often the next option discussed when antidepressants have not worked, or have worked but caused side effects a person could not live with. It acts on brain circuits directly rather than through the bloodstream, which is why its side effect profile differs so much from medication.

TMS uses focused magnetic pulses to stimulate specific regions of the brain. The device is related to MRI technology, but instead of taking pictures, it delivers targeted pulses to the circuits that regulate mood, motivation and emotional processing. There is no surgery, no anesthesia and no drug entering the bloodstream. You sit in a chair, a coil is positioned against your head, and the session begins.

The technology was first FDA-cleared for depression in 2008, and the evidence base has grown substantially since. Today TMS is a mainstream psychiatric treatment, studied in hundreds of randomized trials. Guidelines from the Canadian Network for Mood and Anxiety Treatments (CANMAT, 2016) list rTMS as a first-line option for adults with major depression who have not responded to at least one antidepressant, and the UK's National Institute for Health and Care Excellence judged the evidence adequate for routine use in its 2015 guidance on rTMS for depression.

You will see several names for the same family of treatments: TMS, rTMS (repetitive TMS), dTMS or deep TMS, TBS or iTBS (intermittent theta burst stimulation), and accelerated TMS. All of them belong to a wider field called neuromodulation, alongside electroconvulsive therapy (ECT), vagus nerve stimulation, deep brain stimulation and neurofeedback therapy.

How TMS Works: The Mechanism Explained

TMS works through electromagnetic induction: a changing magnetic field outside the head creates a small electrical current inside the brain. The same four steps happen in every treatment session.

Step 1: Magnetic pulse generation. An electromagnetic coil placed against your scalp generates brief, focused magnetic pulses. These pulses are similar in strength to the field of an MRI machine, about 1.5 to 2 Tesla.

Step 2: Electrical current induction. When the magnetic field passes through the skull, it induces small electrical currents in the targeted brain tissue. This is Faraday's law of electromagnetic induction, the same physics that powers electric generators.

Step 3: Neuronal activation. These induced currents cause neurons in the targeted region to fire. In depression treatment, the primary target is the left dorsolateral prefrontal cortex (DLPFC), a region that imaging studies often find to be underactive in people with depression.

Step 4: Neuroplasticity and circuit change. With repeated sessions, TMS is thought to promote long-term potentiation (LTP), the strengthening of neural connections. Over the course of a protocol, mood-regulation circuits that link the DLPFC with deeper structures such as the subgenual anterior cingulate cortex begin to function more normally. This is why the effects of TMS build over weeks and can persist after treatment ends.

TMS acts on a specific circuit rather than changing neurotransmitter levels across the whole brain and body the way antidepressants do. That is why its side effect profile is so different: it is not associated with the weight gain, sexual side effects, emotional blunting or withdrawal symptoms that some people experience on medication. Researchers still debate exactly which circuit changes drive recovery, and that question is one reason imaging-guided targeting is an active area of study.

Types of TMS: Standard, Deep, Theta Burst, and Accelerated

TMS has evolved since its first FDA clearance in 2008. There are now several distinct protocols, which differ in coil design, pulse pattern and schedule. Knowing the differences makes it easier to have an informed conversation with a provider.

The THREE-D trial, led by Daniel Blumberger at the University of Toronto and published in The Lancet in 2018, randomized 414 adults with depression to standard 10 Hz rTMS or intermittent theta burst. Depression scores improved by nearly the same amount in both groups, and headache was the most common side effect in each. That result is why many clinics now offer theta burst as a routine option. The theta burst stimulation explainer covers the protocol in more detail.

What Conditions Does TMS Treat? An Evidence-Based Guide

TMS treats major depression, OCD, nicotine dependence and depression with anxiety under FDA clearances, and it is studied off label for PTSD, generalized anxiety, chronic pain and traumatic brain injury. The table grades where the evidence stands for each condition by the strength and depth of available research.

Condition	Evidence Grade	FDA Status	Key Findings
Major Depression	ESTABLISHED	FDA-cleared (2008)	58% response and 37% remission in routine US practice (Carpenter, 2012). Hundreds of randomized trials.
OCD	ESTABLISHED	FDA-cleared (2018)	Deep TMS targeting medial prefrontal cortex. 38.1% response vs. 11.1% with sham (Carmi, 2019). Strongest evidence is with the H-coil.
Smoking Cessation	ESTABLISHED	FDA-cleared (2020)	Deep TMS targeting insula and prefrontal cortex. Higher quit rates than sham in the pivotal trial.
Anxious Depression	ESTABLISHED	FDA-cleared (2021)	Deep TMS cleared specifically for MDD with comorbid anxiety symptoms.
Generalized Anxiety	PROMISING	Off-label	Multiple positive studies targeting right DLPFC. Meta-analyses show moderate effect sizes. Larger randomized trials are still needed.
PTSD	PROMISING	Off-label	VA studies show benefit. Right DLPFC targeting. Several positive RCTs but sample sizes remain small.
Chronic Pain	PROMISING	Off-label	Targeting motor cortex for neuropathic pain. European guidelines (Lefaucheur and colleagues, 2020) rate neuropathic pain and fibromyalgia among the better-supported off-label uses.
Traumatic Brain Injury	EARLY	Off-label	Preliminary studies show improvements in cognitive function and depression post-TBI. Larger trials are underway.

TMS for depression

Major depressive disorder is the original and best-studied use of TMS. Most patients who receive it have tried at least one or two antidepressants without enough improvement, which is the group psychiatrists call treatment-resistant. The depression treatment guide places TMS alongside medication, psychotherapy, ketamine and ECT.

TMS for OCD

Deep TMS for obsessive-compulsive disorder targets the medial prefrontal cortex and anterior cingulate cortex. In a multicenter, double-blind trial of 99 adults, Carmi and colleagues (2019, American Journal of Psychiatry) found a 38.1% response rate with active treatment against 11.1% with sham. Sessions usually begin with a brief, personalized symptom provocation. The OCD treatment guide and the TMS for OCD article explain how this fits with exposure and response prevention therapy.

TMS for anxiety and PTSD

For depression with anxiety symptoms, deep TMS has an FDA clearance from 2021. For generalized anxiety disorder and post-traumatic stress disorder on their own, TMS is used off label, usually targeting the right DLPFC. Studies, including work in Veterans Affairs settings, are encouraging but small. See the anxiety treatment guide and the PTSD treatment guide for other options.

TMS for chronic pain, fibromyalgia and brain injury

For pain, TMS usually targets the primary motor cortex rather than the prefrontal cortex. Research has focused on neuropathic pain and fibromyalgia, and the chronic pain treatment guide compares it with other approaches. After traumatic brain injury, studies have looked at post-injury depression and cognition, but the evidence is early and TMS is not cleared for these uses.

TMS for smoking and addiction

Deep TMS aimed at the insula and prefrontal cortex was cleared in 2020 as a short-term aid for adults trying to quit smoking. Research into alcohol, cocaine and other substance use disorders is ongoing but has not led to further clearances. The addiction treatment guide covers the broader options.

Is TMS FDA Approved? Clearances by Year

TMS devices are FDA-cleared, not FDA-approved, which is a regulatory distinction rather than a difference in safety review. Most medical devices of this kind reach the market through the 510(k) or De Novo pathways, which end in a clearance, while new drugs go through approval. Each clearance covers a specific device, coil and indication, so a clinic's device determines what it is cleared to treat.

Anything outside these clearances, including PTSD, generalized anxiety, chronic pain, tinnitus and brain injury, is off-label use. Off-label TMS is legal when a physician judges it appropriate, but insurance rarely covers it, and the evidence for each use should be discussed openly before starting.

TMS for Depression: A Deeper Look at the Evidence

Depression remains the primary and best-studied indication for TMS. The clearest numbers come from people who have already tried antidepressant medication without enough relief.

In routine clinical practice, TMS delivers a 56 to 60% response rate (a 50% or greater reduction in depression symptoms) and a 30 to 37% remission rate (symptoms reduced to a minimal level). The best-known source is the naturalistic study by Carpenter and colleagues (2012), which followed 307 outpatients at 42 US practices whose depression persisted despite medication and found 58% response and 37% remission on clinician ratings. The earlier randomized trial that supported the 2008 clearance (O'Reardon and colleagues, 2007) showed smaller but statistically significant gains over sham, as is typical for tightly controlled trials.

For context, the STAR*D study (Rush and colleagues, 2006) found that remission rates fall with each medication step: 36.8% at the first step, 30.6% at the second, 13.7% at the third and 13.0% at the fourth. TMS results in medication-resistant groups compare well with those later steps, though the studies used different designs and are not head-to-head comparisons.

Real-world registries run by device makers and clinics, some with more than 10,000 patients, report outcomes in a similar range to the trials. Naturalistic studies often report higher response rates than controlled trials, partly because clinicians can adjust protocols based on patient response and partly because they lack a sham group.

How long do the results last? Most studies show that TMS benefits persist for 6 to 12 months in the majority of responders, and some patients maintain improvement for years. When symptoms begin to return, maintenance TMS sessions (weekly or monthly) or a shorter re-induction course can restore the benefit. This durability compares favorably with medication, which often requires ongoing daily use to maintain its effect. The TMS for depression article goes further into relapse and maintenance.

What a TMS Session Actually Looks Like

A TMS session is an outpatient appointment where you sit awake in a chair while a coil rests against your head. The idea of magnetic brain stimulation can sound intimidating, so here is what happens from start to finish.

Before your first session. You will have a consultation with a TMS-trained psychiatrist or other qualified physician. They review your medical history, confirm you are a candidate (no metallic implants near the head and, in most cases, no history of seizures), and discuss which protocol fits. Some clinics use brain imaging (MRI or fMRI) to target the treatment area more precisely.

The first session (mapping). Your first visit takes about 60 minutes because the clinician needs to find your motor threshold, the minimum power level that makes your thumb twitch. This calibration sets the treatment dose for your brain. They also mark the treatment target on your scalp.

A typical treatment session. You sit in a reclining chair, similar to a dentist's chair. The TMS coil is positioned against the left side of your head. You hear clicking sounds and feel a tapping sensation on your scalp, and you wear earplugs. Standard rTMS sessions take 37 to 40 minutes; theta burst sessions take 3 to 10 minutes. You are awake the entire time, and many patients read, watch videos or simply relax.

After each session. You get up and leave. There is no recovery period, no grogginess and no cognitive impairment. Most people drive themselves to and from appointments and return to work the same day. This is one of the most significant practical advantages of TMS over ECT or ketamine infusions.

The full course. A standard protocol involves 5 sessions per week for 4 to 6 weeks, often followed by a short taper. Accelerated protocols such as SAINT compress treatment into 5 days. Many patients begin noticing improvement around weeks 2 to 3, though some notice it earlier and others later.

1. Referral or self-referral, with records of past antidepressant trials.
2. Psychiatric evaluation and safety screening for implants, seizure history and medications.
3. Insurance verification and prior authorization, if you are using insurance.
4. Motor threshold mapping at the first treatment visit.
5. Daily treatment sessions, with depression rating scales repeated every week or two.
6. A taper or follow-up plan, including when to consider maintenance sessions.

Side Effects and Safety

TMS has one of the most favorable safety profiles among psychiatric treatments. The most common side effects are scalp discomfort and headache, and the most serious risk, seizure, is rare. The 2021 international safety guidelines by Simone Rossi and colleagues, published in Clinical Neurophysiology, set the screening and dosing rules most clinics follow.

Common side effects (mild, typically diminish over sessions):

• Scalp discomfort or pain at the treatment site: The most common side effect. Most patients describe a tapping or knocking sensation that can be uncomfortable at first. It usually eases by session 3 to 5 as you acclimate.
• Headache: Reported by about 20 to 30% of patients after early sessions in many studies, and more often in some trials. Usually mild and responsive to over-the-counter pain relievers. It typically fades within the first week of treatment.
• Lightheadedness: Occasionally reported, typically brief and self-resolving.
• Facial twitching: Some patients notice involuntary muscle contractions near the treatment site during stimulation. This is a direct effect of the magnetic field on nearby muscles and is not harmful.
• Hearing: The coil makes a loud clicking sound, so earplugs are standard to protect hearing.

What TMS is not associated with (unlike many antidepressants): weight gain, sexual dysfunction, emotional blunting, nausea, dry mouth, sedation or withdrawal symptoms. Rarely, TMS can trigger mania or hypomania in people with bipolar disorder, which is why screening asks about mood history. For many patients, the absence of systemic medication effects is the main reason they choose TMS.

How TMS Compares to Other Treatments

TMS sits between antidepressants and ECT: more targeted than medication, gentler than ECT, and slower than ketamine to take effect. Choosing a treatment for depression means weighing effectiveness, side effects, time commitment, cost and personal preference. The table compares TMS with the other major options; figures are approximate ranges from the literature and vary by study and clinic.

Factor	TMS	Antidepressants	Ketamine / Esketamine	ECT	Neurofeedback
How it works	Magnetic pulses stimulate brain circuits	Alter neurotransmitter levels systemically	NMDA receptor modulation; rapid synaptogenesis	Electrical seizure induction under anesthesia	Real-time brainwave feedback training
Effectiveness (depression)	56 to 60% response; 30 to 37% remission	40-60% response (first-line); drops sharply with each failed trial	50-70% response; rapid onset (hours to days)	70-80% response; highest efficacy available	Moderate evidence; best for self-regulation and attention
Side effects	Scalp discomfort, headache (mild, transient)	Weight gain, sexual dysfunction, emotional blunting, withdrawal	Dissociation, nausea, blood pressure changes, abuse potential	Memory loss, confusion, requires anesthesia	Minimal; occasional fatigue or headache
Time commitment	20-40 min/day, 5×/week, 4-6 weeks	Daily pill; ongoing indefinitely	2-hour sessions; twice weekly initially, then tapering	Under anesthesia; 2-3×/week, 3-4 weeks; recovery time after each session	30-60 min sessions; 20-40 sessions typical
Cost	$6,000-$12,000 full course	$10-$200/month; ongoing	$400-$800/session; $4,000-$8,000 initial course	$2,500/session; $25,000+ total course	$100-$200/session; $3,000-$6,000 typical course
Insurance coverage	Often covered for treatment-resistant depression by commercial plans and Medicare	Generally well covered	Esketamine nasal spray covered by some plans; IV ketamine rarely covered	Generally covered	Rarely covered by insurance
Onset of improvement	2-4 weeks (standard); days (accelerated)	4-8 weeks	Hours to days	1-2 weeks	Gradual over 10-20+ sessions
Best candidate	Failed 1+ medications; wants non-drug option	First-line treatment; mild-to-moderate depression	Acute suicidality; rapid relief needed; treatment-resistant	Severe, life-threatening depression; catatonia; failed all else	ADHD, anxiety, peak performance; adjunct to other treatments

Ketamine and esketamine work within hours to days, which matters most during a crisis, while TMS takes weeks but needs no monitoring for dissociation afterward. The comparison of TMS and ketamine and the ketamine therapy guide cover that choice; clinics offering infusions are listed in the ketamine clinic directory. ECT remains the most effective option for severe or psychotic depression, and the TMS versus ECT breakdown explains when each is used.

TMS Therapy Cost: What You'll Actually Pay

A full course of TMS therapy is commonly quoted at $6,000 to $12,000 without insurance, and many insured patients pay only their deductible and copays. Prices vary widely by region, device and protocol, so treat the figures below as typical ranges rather than quotes.

Full course (out of pocket): A complete standard TMS protocol of 30 to 36 sessions typically costs between $6,000 and $12,000, depending on your location, the provider, and the specific device and protocol used. Accelerated protocols may be priced similarly or higher because of the intensive scheduling.

Per-session cost: Individual sessions typically run $200 to $400 for standard rTMS and $250 to $500 for deep TMS.

Insurance coverage: Insurance coverage for TMS has expanded in recent years. Most large commercial insurers now cover TMS for treatment-resistant depression, typically defined as failing two or more adequate medication trials, and Medicare also covers it. Coverage for OCD is less consistent. Most plans require prior authorization, and the criteria vary by insurer and state.

What your provider's billing team should do for you: A well run TMS clinic will verify your benefits, obtain prior authorization and handle the paperwork. Ask about this during your initial consultation. If you are paying out of pocket, ask whether the clinic offers payment plans, and get the total course price in writing. The TMS therapy cost breakdown goes into insurance criteria and appeals.

Who Is a Good Candidate for TMS?

The typical TMS candidate is an adult with moderate to severe major depression who has not improved enough on antidepressants or cannot tolerate them. These groups tend to benefit most:

• Treatment-resistant depression: You have tried at least one, and usually two or more, antidepressants at adequate doses for adequate durations without sufficient improvement. This is the core population TMS was designed for.
• Medication intolerance: You have had intolerable side effects from multiple antidepressants and need a non-drug alternative.
• Preference for non-drug treatment: Some people prefer approaches that do not add medication, or their health, pregnancy plans or work make daily medication impractical.
• Moderate to severe depression: TMS has the most impact in moderate to severe depression. Mild depression may respond just as well to psychotherapy and lifestyle changes.
• Ability to commit to the schedule: Standard TMS requires daily appointments for 4 to 6 weeks. You need to live or work close enough to a treatment center to make this practical. Accelerated protocols may be an option if the time commitment is prohibitive.

Who Provides TMS Therapy and How to Choose a Clinic

TMS therapy is prescribed and supervised by a psychiatrist or another licensed physician, and sessions are usually delivered by a trained TMS technician, nurse or nurse practitioner. The physician sets the target and dose, decides whether you are a candidate and reviews progress. Many TMS clinics are psychiatry practices; others are dedicated neuromodulation centers or hospital programs.

What should I ask a TMS clinic?

• Which physician supervises treatment, and how often will they review my progress?
• Which device and coil do you use, and what is it FDA-cleared to treat?
• Do you offer standard rTMS, theta burst, deep TMS or accelerated protocols, and why would you choose one for me?
• How do you measure results, and what happens if I have not improved by week 3 or 4?
• Will you verify my insurance and request prior authorization, and what will I owe in total?

How to read the TMS clinic directory

The TMS clinics listed on Regenerated.com can be filtered by state and city, and each profile shows the treatments a clinic offers. Listing order is not a paid ranking. Featured slots are clearly labeled and capped, Verified means a clinic has completed credential checks rather than paid for placement, and Regenerated.com is free for patients to use. Inclusion in the directory is not an endorsement, so use the questions above on every clinic you call. The guide to Featured, Verified and organic listings explains each label.

Frequently Asked Questions About TMS Therapy

Does TMS hurt?

TMS does not usually hurt, though it can be uncomfortable at first. Most patients describe the sensation as a firm tapping on the scalp, strongest during the first 2 or 3 sessions, and by session 5 most report little discomfort. Your technician can adjust the coil position and ramp the power up gradually to improve comfort. Mild headaches after early sessions are common and usually respond to over-the-counter pain relievers.

How quickly does TMS work?

Most people on a standard TMS schedule start to notice improvement between weeks 2 and 4 of daily sessions. Some respond earlier and some later, so a slow first week is not a sign that treatment has failed, because the neuroplastic changes TMS promotes are cumulative. Accelerated protocols such as SAINT can produce noticeable improvement within 3 to 5 days, although they are offered at fewer clinics.

Can I take my medications during TMS?

Yes, TMS can be used alongside most medications, including antidepressants, anti-anxiety medications and mood stabilizers. Many of the studies behind TMS enrolled patients who stayed on their medications during treatment. Drugs that lower the seizure threshold, such as high-dose bupropion or some stimulants, may need a dose review first, and heavy alcohol use or withdrawal also matters. Bring a complete medication list to your consultation.

What happens if my depression comes back?

If depression returns after TMS, the treatment can be repeated. Relapse is possible with any depression treatment, and studies suggest roughly half to 60% of TMS responders keep their improvement at 12 months. Retreatment courses are often shorter, about 2 to 3 weeks rather than 6, and tend to work at similar rates to the first course. Some patients schedule weekly or monthly maintenance sessions to sustain their improvement.

Does insurance cover TMS therapy?

Most commercial insurance plans and Medicare cover TMS for treatment-resistant depression, usually after you have documented two or more failed antidepressant trials and the clinic has obtained prior authorization. Coverage for OCD is growing but less consistent, and off-label uses are rarely covered. Your TMS clinic should verify your specific benefits before treatment starts. If a claim is denied, ask your provider about an appeal, since initial denials are sometimes overturned.

Is TMS the same as ECT (electroshock therapy)?

No, TMS and ECT are different treatments. ECT passes electrical current through the brain to induce a controlled seizure under general anesthesia and can cause memory loss. TMS uses magnetic fields to stimulate targeted regions without a seizure or anesthesia, and it does not cause memory problems. ECT remains the most effective treatment for severe treatment-resistant depression, while TMS is easier to tolerate and suits a broader range of patients.

Can TMS help with anxiety?

TMS can help with anxiety, with caveats. Deep TMS is FDA-cleared for anxious depression, meaning major depression with significant anxiety symptoms. For standalone generalized anxiety disorder, TMS is used off label: several studies targeting the right DLPFC show benefit, but larger confirmatory trials are still needed. Many patients with both depression and anxiety find that TMS improves both, which is worth discussing with a psychiatrist before you start.

How do I find a TMS provider near me?

Start with your psychiatrist or primary care doctor, who may offer TMS or refer you to a clinic that does. You can also browse the TMS clinic directory by state and city and compare profiles. Before booking, ask which physician supervises treatment, which device and protocol the clinic uses, how it tracks outcomes and whether it handles insurance authorization. The transcranial magnetic stimulation guide lists further questions to ask.

What is the Stanford SAINT protocol and where can I get it?

The Stanford SAINT protocol, also called Stanford Neuromodulation Therapy, is an accelerated, fMRI-guided TMS method that delivers 50 short sessions of intermittent theta burst stimulation over 5 days. In a sham-controlled trial of 29 patients, Cole and colleagues (2022) reported about 79% remission. The FDA cleared it in 2022. Availability is limited, and many clinics offer "SAINT-inspired" accelerated protocols without full fMRI targeting, so ask exactly how a clinic's approach differs.

Can TMS be combined with therapy or other treatments?

Yes, and many clinicians recommend combining them. TMS may help the brain respond to psychotherapy, particularly cognitive behavioral therapy (CBT), by improving how mood circuits function, and some research suggests combined care works better than either alone. TMS can also be paired with medication, exercise, sleep changes and other approaches such as neurofeedback. Tell every clinician involved about the full plan so timing and medications are coordinated.

---

The Bottom Line on TMS Therapy

TMS therapy works by using magnetic pulses to activate specific brain circuits, and it helps most clearly in major depression that has not responded to medication, with FDA clearances for OCD, smoking cessation and anxious depression as well. It works through a different mechanism from medication, modulating the circuits involved in a condition rather than altering neurochemistry throughout the body. Its side effects are mostly local and short-lived. For people whose depression has not improved on antidepressants, it is a well-studied option backed by a growing evidence base.

The field is advancing quickly. Accelerated protocols such as SAINT are shrinking treatment timelines from weeks to days, imaging-guided targeting is being studied as a way to raise response rates, and insurance coverage continues to expand.

If you are living with treatment-resistant depression, OCD or another condition where TMS has shown benefit, it is worth a conversation with a qualified psychiatrist. TMS is not a fringe treatment or only a last resort: it is an evidence-based, FDA-cleared therapy that many people have used to recover from depression. When you are ready to compare providers, the directory of clinics that offer transcranial magnetic stimulation is a practical place to begin.

---

Related Topics